Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Change in Cash (2022 - 2025)

Historic Change in Cash for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to -$913000.0.

  • Century Therapeutics' Change in Cash fell 10819.57% to -$913000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 27486.52%. This contributed to the annual value of $11.9 million for FY2024, which is 13224.06% up from last year.
  • Century Therapeutics' Change in Cash amounted to -$913000.0 in Q3 2025, which was down 10819.57% from $4.9 million recorded in Q2 2025.
  • Century Therapeutics' Change in Cash's 5-year high stood at $69.6 million during Q1 2022, with a 5-year trough of -$27.1 million in Q4 2022.
  • In the last 4 years, Century Therapeutics' Change in Cash had a median value of -$1.4 million in 2022 and averaged $34133.3.
  • In the last 5 years, Century Therapeutics' Change in Cash surged by 22198.86% in 2024 and then crashed by 118378.91% in 2025.
  • Over the past 4 years, Century Therapeutics' Change in Cash (Quarter) stood at -$27.1 million in 2022, then soared by 70.53% to -$8.0 million in 2023, then soared by 172.42% to $5.8 million in 2024, then plummeted by 115.79% to -$913000.0 in 2025.
  • Its Change in Cash stands at -$913000.0 for Q3 2025, versus $4.9 million for Q2 2025 and -$6.6 million for Q1 2025.